Fifteen years after the Institute of Medicine brought public attention to the magnitude and risk posed by errors in clinical practice, patient safety concerns remain a serious public health issue.
By nearly a three-to-one majority, the U.S. House of Representatives passed a bill (HR 2029) that places a two-year moratorium on the 2.3% federal excise tax on medical device sales.